Our CSO, Hiroaki Kato, gave a lecture at The 61st Annual Scientific Meeting of Japan Society of Ningen Dock.

Our CSO, Hiroaki Kato, gave a lecture titled "difficulties and precautions for business development in healthcare x business" at Challenger Day hosted by WOMB.

Our CSO, Hiroaki Kato, gave a lecture titled "Healthtech ~ learning AI-driven medical services " at Human resource development course related to Society5.0 hosted by Kochi prefecture.

Our COO, Daichi Tanaka, gave a presentation at AI Business seminor.

Our CSO, Hiroaki Kato, gave a presentation titled far-sighted insurance reimbursement systems with the progress of AI and digital healthcare at The 1st MDSI Activities hosted by Medical Device Strategy institute.

Our CSO, Hiroaki Kato, gave a lecture titled "The current state of digital healthcare and future development" at TECH for Life Solution Day 2020.

Our COO, Daichi Tanaka, participated in the seminar of anticipating expanding medical devices into US market as a panelist.

Our CEO, Sho Okiyama, participated in G1 Global Conference 2020 "Disruptive Evolution Post-COVID-19 : Geopolitics, Business and Society" as a panelist.

Our CEO, Sho Okiyama, participated in Healthcare Venture Knot 2020.

Our CSO, Hiroaki Kato, was interviewed by Japanese Magazine PRESIDENT.

Aillis participated in NVIDIA GPU TECHNOLOGY CONFERENCE (GTC) AI Startup Pavilion.

Our CSO, Hiroaki Kato, gave a presentation at Yokohama City University's seminar.

Our CSO, Hiroaki Kato, gave a presentation at SDGs Mirai Kaigi 2020 Business Conference.

Our CSO, Hiroaki Kato, was interviewed by MedicalDOC about "What will happen to healthcare? Potential of digital healthcare".

Our CEO, Sho Okiyama, gave a lecture at Waseda Business School.

Our CEO, Sho Okiyama, participated in the 60th annual meeting of The Japanese Respiratory Society.

Our CSO, Hiroaki Kato, gave a presentation at Komatsu University Public Forum.

Our COO, Tanaka, and our business manager, Akane, Launched the IoMD working group at the Japan Digital Therapeutics Association.

Our CSO, Hiroaki Kato, was interviewed by Vision and Strategy, August 20.

Our CEO, Sho Okiyama, participated in 21st Century Advanced Medical Consortium